Evidence map›Paper›PMID 33172531›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2020

Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic.

J L Kadota, T F Reza, T Nalugwa, A Kityamuwesi, G Nanyunja, N Kiwanuka, P Shete, J L Davis, D Dowdy, S Turyahabwe and 2 more

Abstract read
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2021
    Article
  20. The impact of COVID-19 on TB: a review of the data.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

J L KadotaDivision of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA.
T F RezaDivision of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA.
T NalugwaUganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
A KityamuwesiUganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
G NanyunjaUganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
N KiwanukaClinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
P SheteDivision of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
J L DavisDepartment of Epidemiology of Microbial Diseases, Yale School of Medicine, New Haven, CT, USA, Pulmonary, Critical Care, and Sleep Medicine Section, Yale School of Medicine, New Haven, CT, USA.
D DowdyUganda Tuberculosis Implementation Research Consortium, Kampala, Uganda, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
S TuryahabweNational Tuberculosis and Leprosy Programme, Uganda Ministry of Health, Kampala, Uganda.
A KatambaUganda Tuberculosis Implementation Research Consortium, Kampala, Uganda, Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
A CattamanchiDivision of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Hotspot versus clinic-based active case finding for TB in Uganda: A pragmatic randomized trialR01HL138728 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI David Wesley Dowdy, Emily A Kendall · 2017 to 2026
$5.4M
SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trialR01HL130192 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CATTAMANCHI, ADITHYA · 2016 to 2020
$3.2M
UCSF Career Development Program in Implementation Research in Heart and Lung DiseasesK12HL138046 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BIBBINS-DOMINGO, KIRSTEN, CATTAMANCHI, ADITHYA · 2017 to 2021
$2.9M
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS K12 HL138046NHLBI NIH HHS R01 HL130192NHLBI NIH HHS R01 HL138728
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusDisease NotificationSocial IsolationCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralSARS-CoV-2TuberculosisUganda

Identifiers

PMID33172531
PMCPMC7895296

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.